A study carried out by Xu et al. revealed that sEH inhibition promoted a dose-dependent migration and tube formation of endothelial cell from MI patients, which could be abolished by a PPAR-γ antagonist, GW9662. This evidence concerns the gene EPHX2 and myocardial infarction.